Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Control of synaptic function by endocannabinoid-mediated retrograde signaling
Masanobu Kano
Proceedings of the Japan Academy Series B (2014) Vol. 90, Iss. 7, pp. 235-250
Open Access | Times Cited: 119

Showing 26-50 of 119 citing articles:

Endocannabinoids, exercise, pain, and a path to health with aging
Bruce A. Watkins
Molecular Aspects of Medicine (2018) Vol. 64, pp. 68-78
Closed Access | Times Cited: 49
The endocannabinoid system
Aruna Kilaru, Kent D. Chapman
Essays in Biochemistry (2020) Vol. 64, Iss. 3, pp. 485-499
Closed Access | Times Cited: 47
The endocannabinoidome in neuropsychiatry: Opportunities and potential risks
Gerwyn Morris, Ken Walder, Stefan Kloiber, et al.
Pharmacological Research (2021) Vol. 170, pp. 105729-105729
Closed Access | Times Cited: 33
Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome
Viviana Versace, Paola Ortelli, Sabrina Dezi, et al.
Clinical Neurophysiology (2022) Vol. 145, pp. 81-88
Open Access | Times Cited: 27
CB1 Receptor Signaling: Linking Neuroplasticity, Neuronal Types, and Mental Health Outcomes
Qianqian Gao, Muhammad Asim
Neurochemistry International (2025), pp. 105938-105938
Closed Access
Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance
Maria Pyszniak, Jacek Tabarkiewicz, Jarogniew J. Łuszczki
OncoTargets and Therapy (2016) Vol. Volume 9, pp. 4323-4336
Open Access | Times Cited: 46
The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report)
Vincenzo Abbate, Michael Schwenk, Brandon C. Presley, et al.
Pure and Applied Chemistry (2018) Vol. 90, Iss. 8, pp. 1255-1282
Open Access | Times Cited: 44
Effects of the Lipid Metabolites and the Gut Microbiota in ApoE−/− Mice on Atherosclerosis Co-Depression From the Microbiota-Gut-Brain Axis
Ke Hu, Xing-Xing Liao, Xiaoyun Wu, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 19
Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research
Rafael Naime Ruggiero, Matheus Teixeira Rossignoli, Jana Batista De Ross, et al.
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 36
Endocannabinoids exert CB 1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein
Changqing Xu, Douglas J. Hermes, Blessing Nwanguma, et al.
Molecular and Cellular Neuroscience (2017) Vol. 83, pp. 92-102
Open Access | Times Cited: 36
Molecular and neurocircuitry mechanisms of social avoidance
Anne‐Kathrin Gellner, Jella Voelter, Ulrike Schmidt, et al.
Cellular and Molecular Life Sciences (2020) Vol. 78, Iss. 4, pp. 1163-1189
Open Access | Times Cited: 31
Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review
Juan José Fuentes, J. Mayans, M. Guarro, et al.
BMC Psychiatry (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Cannabimimetic phytochemicals in the diet – an evolutionary link to food selection and metabolic stress adaptation?
Jürg Gertsch
British Journal of Pharmacology (2016) Vol. 174, Iss. 11, pp. 1464-1483
Open Access | Times Cited: 31
A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats
Christian Kirkedal, Gregers Wegener, Fabrício A. Moreira, et al.
Acta Neuropsychiatrica (2016) Vol. 29, Iss. 6, pp. 324-329
Closed Access | Times Cited: 29
Cannabinoids as Modulators of Cell Death: Clinical Applications and Future Directions
Bruno M. Fonseca, Natércia Teixeira, Georgina Correia‐da‐Silva
Reviews of physiology, biochemistry and pharmacology (2017), pp. 63-88
Closed Access | Times Cited: 28
The dose-dependent psychomotor effects of intravenous delta-9-tetrahydrocannabinol (Δ9-THC) in humans
Douglas L. Boggs, Jose Cortes-Briones, Toral Surti, et al.
Journal of Psychopharmacology (2018) Vol. 32, Iss. 12, pp. 1308-1318
Closed Access | Times Cited: 26
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices
Changqing Xu, Douglas J. Hermes, Ken Mackie, et al.
Journal of Neuroimmune Pharmacology (2016) Vol. 11, Iss. 2, pp. 316-331
Open Access | Times Cited: 23
Regulation of fear extinction by long-term depression: The roles of endocannabinoids and brain derived neurotrophic factor
Maxwell R. Bennett, Jonathon C. Arnold, Sean N. Hatton, et al.
Behavioural Brain Research (2016) Vol. 319, pp. 148-164
Closed Access | Times Cited: 23
Electroacupuncture Reduces Visceral Pain Via Cannabinoid CB2 Receptors in a Mouse Model of Inflammatory Bowel Disease
Hong Zhang, Wei He, Xuefei Hu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 13
Major dorsoventral differences in the modulation of the local CA1 hippocampal network by NMDA, mGlu5, adenosine A2A and cannabinoid CB1 receptors
Stylianos Kouvaros, Costas Papatheodoropoulos
Neuroscience (2016) Vol. 317, pp. 47-64
Closed Access | Times Cited: 21
Direct presynaptic and indirect astrocyte-mediated mechanisms both contribute to endocannabinoid signaling in the pedunculopontine nucleus of mice
A. Kovács, Cs. Bordás, Tamás Bı́ró, et al.
Brain Structure and Function (2016) Vol. 222, Iss. 1, pp. 247-266
Closed Access | Times Cited: 20
Cannabinoids in Health and Disease
Rosaria Meccariello, Rosanna Chianese
InTech eBooks (2016)
Open Access | Times Cited: 20
Recent advances in the understanding of the aetiology and therapeutic strategies in burning mouth syndrome: Focus on the actions of cannabinoids
Sónia R. Pereira, Johana Tello Velasquez, Sarah Duggan, et al.
European Journal of Neuroscience (2020) Vol. 55, Iss. 4, pp. 1032-1050
Open Access | Times Cited: 18
Influence of cannabinoids upon nerve-evoked skeletal muscle contraction
Dengyun Ge, G. Lorenzo Odierna, William D. Phillips
Neuroscience Letters (2020) Vol. 725, pp. 134900-134900
Closed Access | Times Cited: 18
The Endocannabinoid System Contributes to Electroacupuncture Analgesia
Iona MacDonald, Yi‐Hung Chen
Frontiers in Neuroscience (2021) Vol. 14
Open Access | Times Cited: 16

Scroll to top